Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 78M | 154M | 376M | -24M |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | 19M | 22M | 21M | 15M |
| Other operating expenses | — | — | — | — |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | — | — | — | — |
| Pretax income | 50M | 122M | 346M | -48M |
| Tax provision | — | — | — | — |
| Net income | 50M | 122M | 346M | -48M |
| Basic EPS | 0.0 | 0.1 | 0.4 | -0.1 |
| Diluted EPS | 0.0 | 0.1 | 0.4 | -0.1 |
| Basic average shares | 47.5M | 45.6M | 41.7M | 38.2M |
| Diluted average shares | 47.6M | 45.8M | 41.9M | 38.2M |
| EBITDA | — | — | — | — |
| Net income from continuing op. | 50M | 122M | 346M | -48M |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |